Description
TEVIMBRA is a programmed death receptor-1 (PD-1)-blocking antibody
indicated for:
Esophageal Cancer
• in combination with platinum-containing chemotherapy for the first-line treatment of adults with unresectable or metastatic esophageal squamous cell carcinoma (ESCC) whose tumors express PD-L1 (≥1).
• as a single agent in adults with unresectable or metastatic esophageal squamous cell carcinoma (ESCC) after prior systemic chemotherapy that did not include a PD-(L)1 inhibitor.
Gastric Cancer
• in combination with platinum and fluoropyrimidine-based chemotherapy in adults for the first line treatment of unresectable or metastatic HER2- negative gastric or gastroesophageal junction adenocarcinoma whose tumors express PD-L1 (≥1).
Additional information
| Brand | TEVIMBRA® |
|---|---|
| Generic name | Tislelizumab injection |
| Form | Parenteral |
| Strength | 100mg/10mL |
| Manufacturer | BeOne |
| Documents | Either PO or prescription |
| Storage | Store in a refrigerator at 2 – 8°C. |
| Global delivery time | 10-20 days |
| Pay attention | Shipment should be organized from our Company with airlines only (Not FedEx, DHL, EMS, Aramex, UPS), at the specified storage condition along with one data logger. |
Related products
-
-
+ wishlist+ compare
Enhertu 100mg Injection
Original price was: $2,495.00.$1,650.00Current price is: $1,650.00.Add to cart -
-
+ wishlist+ compare
Cidofovir injection, 375mg/5ml
Original price was: $1,391.00.$650.00Current price is: $650.00.Add to cart
Reviews
There are no reviews yet.